Volume 17, Number 5—May 2011
Travel-related Dengue Virus Infection, the Netherlands, 2006–2007
|Traveler no.: age, y/sex||Country of birth||Destination country (region)||Previous times traveled to developing country||Travel-related signs and symptoms||Dengue-like illness||Vaccinated against yellow fever||IgM-ratio†||IgG-ratio†|
|1: 33/M||The Netherlands||Philippines (Asia)||2–5||Fever, myalgia, headache, retro-orbital pain, diarrhea||Yes||Never||NA||17.65|
|2: 62/M||Germany||Indonesia (Asia)||0||Skin rash, diarrhea||No||Never||51.79||38.9|
|3: 64/M||The Netherlands||Sri Lanka (Asia)||>10||Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea||Yes||In 1992||NA||28.3|
|4: 41/M||The Netherlands||Cambodia, Thailand, Malaysia, Philippines (Asia)||>10||None||No||Never||NA||46.27|
|5: 36/F||The Netherlands||Thailand, Singapore (Asia)||6–10||Diarrhea||No||Never||3.34||NA|
|6: 37/F||The Netherlands||Indonesia (Asia)||0||Fever, myalgia, headache, retro-orbital pain, skin rash||Yes||Never||48.66||142.25|
|7: 28/M||The Netherlands||Vietnam (Asia)||2–5||None||No||Never||2.78||NA|
|8: 27/M||The Netherlands||India, Nepal (Asia)||2–5||Diarrhea||No||Never||5.11||NA|
|9: 68/M||The Netherlands||Surinam (Latin America)||1||None||No||In 2000||NA||8.91|
|10: 26/F||The Netherlands||Argentina, Bolivia, Brazil, Chili, Uruguay (Latin America)||0||Fever, myalgia, arthralgia, headache, skin rash, diarrhea||Yes||For this trip||NA||26.67|
|11: 23/F||The Netherlands||Surinam (Latin America)||1||Skin rash, diarrhea||No||For this trip||NA||72.82|
|12: 54/F||The Netherlands||Gambia (Africa)||2–5||Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea||Yes||For this trip||NA||26.87|
|13: 27/M||The Netherlands||Mali, Burkina Faso (Africa)||2–5||Skin rash, diarrhea||No||In 2000||18.15||NA|
|14: 52/M||The Netherlands||Madagascar (Africa)||6–10||Diarrhea||No||In 1992||8.82||NA|
*Ig, immunoglobulin; NA, ratio not available.
†Posttravel to pretravel. If the posttravel sample test results were negative for a type of anti-DENV, the pretravel serum sample was not tested for that type of antibody.
Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.